News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,252 Results
Type
Article (41863)
Company Profile (405)
Press Release (653984)
Section
Business (208381)
Career Advice (2058)
Deals (35977)
Drug Delivery (86)
Drug Development (83193)
Employer Resources (170)
FDA (16277)
Job Trends (15048)
News (351861)
Policy (33086)
Tag
Academia (2642)
Africa (743)
Alliances (50648)
Alzheimer's disease (1187)
Approvals (16198)
Arizona (181)
Artificial intelligence (73)
Asia (38343)
Australia (6373)
Bankruptcy (359)
Best Places to Work (11466)
Biosimilars (65)
Biotechnology (303)
C2C Services and Suppliers (79905)
California (1858)
Canada (915)
Cancer (418)
Career advice (1717)
Cell therapy (127)
China (137)
Clinical research (64901)
Collaboration (141)
Colorado (73)
Compensation (73)
Connecticut (73)
COVID-19 (2552)
Cystic fibrosis (76)
Data (231)
Diabetes (81)
Diagnostics (6041)
Drug pricing (70)
Earnings (84883)
Employer resources (144)
Europe (83529)
Events (111471)
Executive appointments (141)
FDA (16476)
Florida (256)
Funding (141)
Gene therapy (99)
GLP-1 (540)
Government (4389)
Healthcare (18983)
Hotbed/Location (489314)
Illinois (260)
Indiana (146)
Infectious disease (2580)
Inflammatory bowel disease (94)
Interviews (323)
IPO (16473)
Job creations (3700)
Job search strategy (1472)
Kansas (96)
Layoffs (420)
Legal (7931)
Lung cancer (94)
Manufacturing (83)
Maryland (387)
Massachusetts (1557)
Medical device (13218)
Medtech (13223)
Mergers & acquisitions (19339)
Metabolic disorders (257)
Michigan (123)
Minnesota (219)
Neuroscience (1328)
New Jersey (555)
New York (575)
NextGen Class of 2024 (6727)
Non-profit (4543)
North Carolina (632)
Northern California (804)
Obesity (154)
Ohio (104)
Opinion (190)
Patents (67)
Pennsylvania (572)
People (57263)
Pharmaceutical (79)
Phase I (20290)
Phase II (28629)
Phase III (21236)
Pipeline (103)
Postmarket research (2591)
Preclinical (8714)
Press Release (68)
Rare diseases (135)
Real estate (6007)
Recruiting (65)
Regulatory (21685)
Research institute (2421)
Resumes & cover letters (358)
South America (1112)
Southern California (738)
Startups (3760)
Texas (232)
United States (8533)
Vaccines (483)
Washington State (255)
Weight loss (137)
Date
Today (79)
Last 7 days (667)
Last 30 days (2248)
Last 365 days (38328)
2024 (26522)
2023 (41082)
2022 (52356)
2021 (56846)
2020 (55030)
2019 (47564)
2018 (35808)
2017 (33127)
2016 (32468)
2015 (38538)
2014 (32312)
2013 (27257)
2012 (29360)
2011 (30002)
2010 (28122)
696,252 Results for "forma therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Forma Medical Granted FDA Clearance For Optimal Plating System Enabling a Multi-Faceted Growth Strategy for MIS Forefoot Portfolio
July 9, 2024
·
2 min read
Business
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
Gain Therapeutics, Inc. announces that Matthias Alder has departed the Company in order to pursue other opportunities.
June 27, 2024
·
5 min read
Press Releases
ReCerise Therapeutics Inc. Selected for Government Project by MOTIE
Initiates Development of Tailored Innovative Targeted Therapy for Refractory Cancer ReCerise Therapeutics Inc., has announced its selection for a grant from the Ministry of Trade, Industry and Energy of South Korea.
July 1, 2024
·
2 min read
Pharm Country
Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc.
Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced plans to accelerate its development initiatives in obesity and cardiometabolic disease through the acquisition of the assets of Better Therapeutics, Inc.
May 22, 2024
·
7 min read
Bausch Health’s Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA(R)
Bausch + Lomb Corporation (NYSE/TSX:BLCO), a subsidiary of Bausch Health Companies Inc. (NYSE/TSX:BHC), announced that it has disclosed certain historical and pro forma financial information with respect to its previously announced proposed acquisition of XIIDRA® (lifitegrast ophthalmic solution) 5% and certain other ophthalmology assets (the “Acquisition”) on a Current Report on Form 8-K and on its SEDAR+ (www.sedarplus.ca) profile.
September 6, 2023
·
3 min read
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
Business
InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of $96M;
InMode Ltd., a leading global provider of innovative medical technologies, announced its consolidated financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
17 min read
Pharm Country
Forma Medical Launches OptimalHT the World’s First Minimally Invasive Instrumented Hammertoe Arthrodesis Procedure After 50+ Procedures
Forma Medical , an emerging innovator in medical device technologies, announces today the launch of OptimalHT, the world’s first instrumented Minimally Invasive Surgery (MIS) Hammertoe Arthrodesis procedure, that has treated more than 50 hammertoe deformities.
September 6, 2023
·
2 min read
Biotech Bay
CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236
CERo Therapeutics Holdings, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announced it successfully executed pre-IND manufacturing activities for its lead therapeutic, CER-1236.
June 13, 2024
·
4 min read
1 of 69,626
Next